Patients with hereditary hemochromatosis reach safe range of transferrin saturation sooner with erythrocytaphereses than with phlebotomies

INTRODUCTION: For the maintenance treatment of patients with hereditary hemochromatosis (HH), it is advised to keep the transferrin saturation (TSAT) <70% to prevent formation of non‐transferrin‐bound iron and labile plasma iron. The period of the initial iron depletion may last up to 1 year or l...

Descripción completa

Detalles Bibliográficos
Autores principales: Rombout‐Sestrienkova, Eva, Brandts, Lloyd, Koek, Ger H., van Deursen, Cees Th. B. M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2021
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299622/
https://www.ncbi.nlm.nih.gov/pubmed/34897777
http://dx.doi.org/10.1002/jca.21956

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299622/
https://www.ncbi.nlm.nih.gov/pubmed/34897777
http://dx.doi.org/10.1002/jca.21956

Ejemplares similares